Perla Giles, a rising senior majoring in molecular microbiology, and David Lee, a rising senior majoring in chemistry, have been chosen to participate in the Beckman Scholars Program, which provides in-depth research experiences for exceptionally talented undergraduate students.
As U.S. public health funding falters, WashU experts warn that vital global data systems protecting women and children from violence are in danger of disappearing.
Rebecca Messbarger, professor of Italian in Arts & Sciences, has published a chapter titled “Popes, the Body, Medicine, and the Cult of Saints after Trent” as part of “The Cambridge History of the Papacy, Volume III: Civil Society.”
Robi Mitra at WashU Medicine has received the Chancellor’s Award for Innovation and Entrepreneurship. In addition, in 2024 WashU jumped 11 places to No. 26 on the National Academy of Inventors list of the top 100 U.S. universities granted U.S. utility patents.
Charlie Fioriglio, a rising senior studying physics and chemistry in Arts & Sciences at Washington University in St. Louis, has been named an Astronaut Scholar, a competitive fellowship for exceptional undergraduate students pursuing degrees in science, technology, engineering and math.
Barbara W. Trautner, MD, PhD, an internationally recognized physician-scientist, has been named the new co-director of the Division of Infectious Diseases in the Department of Medicine at WashU Medicine.
Josh Walehwa has been appointed associate vice chancellor and chief of staff for Nichol Luoma, executive vice chancellor for administration and chief administrative officer at Washington University in St. Louis, beginning June 2.
As the Oklahoma Legislature clears the way for autonomous practice by nurse practitioners, it’s time for a broader conversation regarding the scope and duration of training and certification needed to independently provide care to patients of all types, says Patrick Aguilar, MD, a business of health expert at WashU Olin Business School.
An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.